MASSACHUSETTS FINANCIAL SERVICES CO /MA/

Position in MDXG — Mimedx Group, Inc.

CIK 912938 Boston, MA

Position in MDXG

as of Mar 31, 2026 · filed May 14, 2026 Compact

Position Value

$247,032

-$187,628 QoQ

Shares Held

62,540

-2.6% QoQ

Ownership

0.042%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Jun 2023

12 quarters on record

Voting authority Sole 83.38983050847457.ToString("F0")% Shared 16.610169491525422.ToString("F0")% None 0.ToString("F0")%

Healthcare · as of Mar 31, 2026

MASSACHUSETTS FINANCIAL SERVICES CO /MA/ holds $1,374,765,738 across 53 Biotechnology names. MDXG ranks #52 (0.0% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	ASND	Ascendis Pharma A/S	1,860,669	$425,590,816
2	TECH	BIO-TECHNE Corp	3,733,248	$195,099,537
3	ALNY	Alnylam Pharmaceuticals, Inc.	496,004	$164,112,841
4	VRTX	Vertex Pharmaceuticals Inc / Ma	327,498	$146,240,953
5	LGND	Ligand Pharmaceuticals Inc	411,543	$82,164,559
6	BNTX	BioNTech SE	670,514	$59,595,283
7	IONS	Ionis Pharmaceuticals Inc	666,116	$50,018,650
8	INCY	Incyte Corp	410,729	$38,657,809

12 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$247,032	62,540	-2.6%	Shares	Defined	2026-05-14
2025-12-31	$434,660	64,204	-53.3%	Shares	Sole	2026-01-22
2025-09-30	$960,364	137,588	-20.0%	Shares	Sole	2025-10-29
2025-06-30	$1,050,926	172,001	+1.2%	Shares	Sole	2025-08-08
2025-03-31	$1,291,103	169,882	-2.2%	Shares	Sole	2025-05-02
2024-12-31	$1,671,407	173,743	-2.9%	Shares	Sole	2025-02-12
2024-09-30	$1,057,488	178,932	-2.4%	Shares	Sole	2024-11-12
2024-06-30	$1,270,012	183,263	+3.5%	Shares	Sole	2024-08-09
2024-03-31	$1,363,824	177,120	-0.2%	Shares	Sole	2024-05-14
2023-12-31	$1,556,841	177,519	-3.1%	Shares	Sole	2024-02-08
2023-09-30	$1,334,995	183,127	-3.7%	Shares	Sole	2023-11-08
2023-06-30	$1,256,818	190,139	—	Shares	Sole	2023-08-09
No filing history on record for this holder in this stock.